DK1121114T3 - Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser - Google Patents

Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser

Info

Publication number
DK1121114T3
DK1121114T3 DK99941238T DK99941238T DK1121114T3 DK 1121114 T3 DK1121114 T3 DK 1121114T3 DK 99941238 T DK99941238 T DK 99941238T DK 99941238 T DK99941238 T DK 99941238T DK 1121114 T3 DK1121114 T3 DK 1121114T3
Authority
DK
Denmark
Prior art keywords
mania
medication
preparation
treatment
bipolar disorders
Prior art date
Application number
DK99941238T
Other languages
Danish (da)
English (en)
Inventor
Atul Chandra Pande
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1121114T3 publication Critical patent/DK1121114T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99941238T 1998-10-16 1999-08-18 Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser DK1121114T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10453598P 1998-10-16 1998-10-16
PCT/US1999/018981 WO2000023067A1 (en) 1998-10-16 1999-08-18 Method for the treatment of mania and bipolar disorder

Publications (1)

Publication Number Publication Date
DK1121114T3 true DK1121114T3 (da) 2007-04-10

Family

ID=22300998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99941238T DK1121114T3 (da) 1998-10-16 1999-08-18 Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser

Country Status (16)

Country Link
US (1) US6359005B1 (ko)
EP (1) EP1121114B1 (ko)
JP (1) JP2002527474A (ko)
KR (1) KR100697734B1 (ko)
AU (1) AU762599B2 (ko)
CA (1) CA2344407C (ko)
CY (1) CY1106020T1 (ko)
DE (1) DE69934813T2 (ko)
DK (1) DK1121114T3 (ko)
ES (1) ES2279631T3 (ko)
HU (1) HUP0103842A3 (ko)
IL (1) IL142225A (ko)
NZ (1) NZ510920A (ko)
PT (1) PT1121114E (ko)
WO (1) WO2000023067A1 (ko)
ZA (1) ZA200102561B (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
AU2002230398A1 (en) 2000-10-06 2002-04-29 Xenoport, Inc. Bile-acid conjugates for providing sustained systemic concentrations of drugs
AU2002211863A1 (en) 2000-10-06 2002-04-15 Xenoport, Inc. Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
US7022678B2 (en) * 2001-03-30 2006-04-04 Warner-Lambert Company Pregabalin lactose conjugates
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
KR20040016882A (ko) 2001-06-11 2004-02-25 제노포트 인코포레이티드 감소된 독성을 가진 ｇａｂａ 유사체 프로드러그의 구강투여용 투여 형태물
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7420002B2 (en) 2001-06-11 2008-09-02 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
WO2003077902A1 (en) 2002-02-19 2003-09-25 Xenoport, Inc. Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
AU2003243180A1 (en) 2002-05-17 2003-12-12 Xenoport, Inc. Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
US7060727B2 (en) 2002-12-11 2006-06-13 Xenoport, Inc. Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
WO2004054565A1 (en) * 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
SG146643A1 (en) 2003-09-17 2008-10-30 Xenoport Inc Treating or preventing restless legs syndrome using prodrugs of gaba analogs
DK1677767T3 (da) 2003-10-14 2011-10-24 Xenoport Inc Krystallinsk form af gamma-aminobutyrsyre-analog
PT1727620E (pt) * 2004-03-12 2007-11-05 Warner Lambert Co Ligandos de biofosfina c1-simétricos e a sua utilização na síntese assimétrica da pregabalina
WO2005095424A1 (en) * 2004-04-01 2005-10-13 Warner-Lambert Company Llc Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
AU2005256945B2 (en) 2004-06-21 2008-11-13 Upjohn Us 1 Llc Preparation of pregabalin and related compounds
EP1811986B1 (en) 2004-11-04 2014-03-26 XenoPort, Inc. Gabapentin prodrug sustained release oral dosage forms
JP2010043063A (ja) 2008-05-09 2010-02-25 Agency For Science Technology & Research 川崎病の診断及び治療
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin
KR101035974B1 (ko) * 2011-02-28 2011-05-23 (주) 경화엔지니어링 하수, 폐수 및 침출수 관거용 탈취장치
BR112020022885A2 (pt) 2018-05-14 2021-03-23 Xgene Pharmaceutical Inc. formas cristalinas de conjugados de fármacos de carbamato de 1-(aciloxi)-alquila de naproxeno e pregabalina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283281B6 (sk) * 1992-05-20 2003-05-02 Northwestern University Deriváty gamaaminomaslovej kyseliny, spôsoby a medziprodukty na ich výrobu, ich použitie a farmaceutické prostriedky
US5510381A (en) * 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
DE69737719D1 (de) * 1996-10-23 2007-06-21 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
WO1999008667A2 (en) * 1997-08-19 1999-02-25 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants

Also Published As

Publication number Publication date
CY1106020T1 (el) 2011-04-06
WO2000023067A1 (en) 2000-04-27
AU762599B2 (en) 2003-06-26
US6359005B1 (en) 2002-03-19
EP1121114A1 (en) 2001-08-08
HUP0103842A3 (en) 2003-04-28
NZ510920A (en) 2002-08-28
ZA200102561B (en) 2002-09-30
ES2279631T3 (es) 2007-08-16
AU5493099A (en) 2000-05-08
EP1121114B1 (en) 2007-01-10
KR100697734B1 (ko) 2007-03-22
DE69934813D1 (de) 2007-02-22
PT1121114E (pt) 2007-03-30
JP2002527474A (ja) 2002-08-27
CA2344407C (en) 2007-01-09
KR20010080165A (ko) 2001-08-22
IL142225A (en) 2009-09-22
DE69934813T2 (de) 2007-10-11
CA2344407A1 (en) 2000-04-27
HUP0103842A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
DK1121114T3 (da) Anvendelse af GABA-analoger til fremstilling af et medikament til behandling af mani og bipolære lidelser
DK0966436T3 (da) Arylsulfonamider og analoger deraf og anvendelse deraf til behandling af neurodegenerative lidelser
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1039882T3 (da) Terapeutisk formulering til indgivelse af tolterodin med kontrolleret frigivelse
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
ATE357941T1 (de) Vorrichtungen zur medikamentverabreichung
NO306446B1 (no) Oralt farmasöytisk preparat omfattende tramadol med regulert frigjöringsvirkning
DK200200116U4 (da) Mundhygiejnepræparat til behandling af halitosis
DK1117394T3 (da) Anvendelse af carnitiner og resveratrol til fremstilling af et præparat til forebyggelse eller terapeutisk behandling af cerabrale lidelser forårsaget af aldring og anvendelse af neurotoksiske medikamenter
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK0751129T6 (da) Substituerede dihydrodibenzo(b,f)azepiner, fremgangsmåde til fremstilling deraf, deres anvendelse i behandlingen af nogle lidelser i centralnervesystemet og farmaceutiske sammensætninger indeholdende disse
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
BR9707210A (pt) Preparado de combinação farmacêutico a partir de análogos de ihrh e antiestrogênios para o tratamento de distúrbios ginecológicos
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DK1007024T3 (da) Doseringsformer af sertralin med forsinket frigivelse
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20012976D0 (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
DK632388D0 (da) Pharmaceutisk middel til behandling af hypolipidaemi hos pattedyr
BR9608595A (pt) Utilização de n-cicloexil benzamidas para o tratamento de aglições intestinais
DK316386A (da) Terapeutisk aktive benzamider og fremgangsmaade til fremstilling af saadanne
DK236489A (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser